⌘K

Home/Filings/4/0001144204-14-065999

4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-14-065999

CIK 0001235007operating

View on SEC.gov Company Profile

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 2:17 PM ET

Size

6.9 KB

Accession

0001144204-14-065999

Insider Transaction Report

Form 4

Period: 2014-11-05

ENDOCYTE INCECYT

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2014-11-05$1.91/sh+19,060$36,405→ 225,965 total
Exercise/Conversion
Stock Option (right to buy)
2014-11-05−19,060→ 0 total
Exercise: $1.91Exp: 2016-08-31→ Common Stock (19,060 underlying)

Footnotes (2)

[F1]Includes 2319 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2014.
[F2]The option is fully vested and immediately exercisable.

Documents

1 file

4
v393628_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235007

Filing Metadata

Form type: 4
Filed: Nov 6, 7:00 PM ET
Accepted: Nov 7, 2:17 PM ET
Size: 6.9 KB

View on SEC.gov